|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2008-5-5
|
|
pubmed:abstractText |
beta-blocker therapy is an established therapeutic strategy for systolic heart failure. However, its benefits in diastolic heart failure (DHF) are controversial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1388-9842
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
446-53
|
|
pubmed:dateRevised |
2011-6-8
|
|
pubmed:meshHeading |
pubmed-meshheading:18400557-Adrenergic beta-Antagonists,
pubmed-meshheading:18400557-Animals,
pubmed-meshheading:18400557-Bisoprolol,
pubmed-meshheading:18400557-Disease Models, Animal,
pubmed-meshheading:18400557-Dose-Response Relationship, Drug,
pubmed-meshheading:18400557-Heart Failure, Diastolic,
pubmed-meshheading:18400557-Hypertension,
pubmed-meshheading:18400557-Inflammation,
pubmed-meshheading:18400557-Male,
pubmed-meshheading:18400557-Oxidative Stress,
pubmed-meshheading:18400557-Rats,
pubmed-meshheading:18400557-Rats, Inbred Dahl,
pubmed-meshheading:18400557-Survival Analysis
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Beneficial effects of bisoprolol on the survival of hypertensive diastolic heart failure model rats.
|
|
pubmed:affiliation |
Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
